Literature DB >> 2826435

Solubilization and characterization of active neurotensin receptors from mouse brain.

J Mazella1, J Chabry, P Kitabgi, J P Vincent.   

Abstract

Neurotensin receptors were solubilized from mouse brain using the zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS). The binding of 125I-labeled [Tyr3]neurotensin to the soluble fraction was time-dependent, saturable, and reversible. Unlabeled neurotensin and its analogues acetylneurotensin (8-13), neurotensin (9-13), and neurotensin (1-12) competitively antagonized the binding of 125I-labeled [Tyr3]neurotensin to CHAPS-solubilized extracts with relative potencies similar to those observed with membrane-bound receptors. Scatchard analysis of equilibrium binding data indicated that the soluble extract contained a single class of neurotensin binding sites with a Kd of 0.36 nM and a Bm of 63 fmol/mg. As already observed with membrane-bound receptors, the affinity of neurotensin for the soluble binding activity was decreased by Na+ ions. By contrast, soluble receptors were no longer sensitive to GTP and the antihistamine drug levocabastine. A molecular weight of about 100,000 was determined for soluble neurotensin receptors both under native conditions by gel filtration on Ultrogel AcA 34 and under denaturating conditions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after photoaffinity labeling.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826435

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Purification of an apolipoprotein A binding protein from mouse adipose cells.

Authors:  R Barbaras; P Puchois; J C Fruchart; A Pradines-Figueres; G Ailhaud
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

2.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

3.  Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Authors:  I Dubuc; P Sarret; C Labbé-Jullié; J M Botto; E Honoré; E Bourdel; J Martinez; J Costentin; J P Vincent; P Kitabgi; J Mazella
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

4.  Purification of a rat neurotensin receptor expressed in Escherichia coli.

Authors:  J Tucker; R Grisshammer
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

5.  Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation.

Authors:  S Y Choi; H D Chae; T J Park; H Ha; K T Kim
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice.

Authors:  Moonnoh R Lee; David J Hinton; Jane Y Song; Kyung Won Lee; Christopher Choo; Heidi Johng; Sencan S Unal; Elliott Richelson; Doo-Sup Choi
Journal:  Pharmacol Biochem Behav       Date:  2010-02-01       Impact factor: 3.533

7.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.